Brand Genetics Announces Angel Investment in Synthsight Ltd

                                                            6th August 2024
                                                        
                                                              |   
                                                                            3 minute read

We’re excited to announce our angel investment in Synthsight Ltd, a London-based AI startup specialising in research technology (Res-Tech SaaS).

Brand Genetics has committed substantial seed funding in exchange for a significant equity stake in Synthsight Ltd. This investment will support Synthsight’s mission to develop AI digital workers, or “Synths,” for the research industry. These Synths, with expert research skills, are designed to work as salaried research assistants alongside human researchers.

Synthsight’s vision is to become the “Manpower of AI”, leading the new global market in staffing ‘AI employees’ for organisations. With early prototypes already placed in industry, and a collaboration with a top university planned, Synthsight hopes to transform the research industry.

As part of this agreement, Brand Genetics CEO Tom Ellis will join Synthsight’s board as a director, providing strategic guidance as they prepare for their initial launch and commercialisation.

We are proud to support Synthsight in their journey to redefine the future of research with AI. Stay tuned for updates!